40.63
Artivion Inc stock is traded at $40.63, with a volume of 292.87K.
It is up +1.07% in the last 24 hours and down -0.17% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$40.20
Open:
$40.07
24h Volume:
292.87K
Relative Volume:
0.67
Market Cap:
$1.92B
Revenue:
$384.90M
Net Income/Loss:
$-851.00K
P/E Ratio:
-2,031.50
EPS:
-0.02
Net Cash Flow:
$12.83M
1W Performance:
-0.29%
1M Performance:
-0.17%
6M Performance:
+73.86%
1Y Performance:
+56.75%
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AORT
Artivion Inc
|
40.63 | 1.90B | 384.90M | -851.00K | 12.83M | -0.02 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-13-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Jun-17-25 | Initiated | Canaccord Genuity | Buy |
Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
Sep-27-22 | Reiterated | Lake Street | Buy |
Aug-08-22 | Initiated | Lake Street | Buy |
Mar-03-22 | Initiated | Stifel | Buy |
View All
Artivion Inc Stock (AORT) Latest News
Risk adjusted return profile for Artivion Inc. analyzed2025 Technical Patterns & Risk Managed Investment Signals - newser.com
What catalysts could drive Artivion Inc. stock higherM&A Rumor & High Accuracy Swing Trade Signals - newser.com
Is Artivion Inc. stock safe for conservative investors2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Can Artivion Inc. hit a new high this monthOil Prices & AI Driven Price Forecasts - newser.com
What data driven models say about Artivion Inc.’s futureJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Artivion (AORT) Shows Promising Results from Key Cardiovascular Trials - GuruFocus
How sustainable is Artivion Inc. stock dividend payoutPortfolio Value Report & Weekly Momentum Picks - newser.com
Artivion reports positive data from AMDS trials for aortic disease - Investing.com India
Applying big data sentiment scoring on Artivion Inc.Volume Spike & Daily Growth Stock Tips - newser.com
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire
Stocks with Diverging Prospects: Snowflake a Buy, Mercury & Artivion a SellNews and Statistics - IndexBox
Candlestick signals on Artivion Inc. stock today2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Is Artivion Inc. (CYL) stock positioned for secular growthTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Artivion Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Artivion stock price target raised to $47 from $42 at Citizens - Investing.com UK
Using data filters to optimize entry into Artivion Inc.Earnings Growth Summary & Community Verified Watchlist Alerts - newser.com
Trend analysis for Artivion Inc. this week2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Custom watchlist performance reports with Artivion Inc.Weekly Stock Report & Technical Analysis for Trade Confirmation - newser.com
Has Artivion Inc. formed a bullish divergenceTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Published on: 2025-10-09 03:33:28 - newser.com
How Artivion Inc. stock reacts to stronger dollarEarnings Recap Summary & Daily Entry Point Alerts - newser.com
Why analysts maintain buy rating on Artivion Inc. (CYL) stock2025 Analyst Calls & Detailed Earnings Play Strategies - newser.com
Artivion's (AORT) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
State of Alaska Department of Revenue Increases Holdings in Artivion, Inc. $AORT - Defense World
What drives Artivion Inc CYL stock priceSmall Cap Stock Opportunities & Free ETF and Mutual Fund Comparisons - earlytimes.in
Brokerages Set Artivion, Inc. (NYSE:AORT) PT at $43.13 - Defense World
Artivion Inc. stock retracement – recovery analysisQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
How to use Fibonacci retracement on Artivion Inc.Portfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Understanding Artivion Inc.’s price movementEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Why retail investors pile into Artivion Inc. stockWeekly Trade Analysis & Verified Swing Trading Watchlists - newser.com
Will Artivion Inc. stock keep raising dividendsMarket Movement Recap & Technical Confirmation Alerts - newser.com
What insider trading reveals about Artivion Inc. stockMarket Growth Summary & Precise Swing Trade Alerts - newser.com
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):